Allergy Therapeutics PLC Annual Report and Accounts (1587V)
October 23 2014 - 10:19AM
UK Regulatory
TIDMAGY
RNS Number : 1587V
Allergy Therapeutics PLC
23 October 2014
23 October 2014
Allergy Therapeutics plc
("Allergy Therapeutics" or the "Company")
Annual Report and Accounts
Allergy Therapeutics plc, the fully integrated specialty
pharmaceutical company, announces that the Annual Report and
Accounts of the Company for the year ended 30 June 2014 and Notice
of Annual General Meeting have been posted to shareholders.
The Annual Report and Accounts and Notice of the Annual General
Meeting are available on the Company's website in the Investor
Relations section. They can be located at
http://www.allergytherapeutics.com/Reports%20and%20Presentations%20Sub.aspx
for the Annual Report and Accounts and
http://www.allergytherapeutics.com/AGM.aspx for the Notice of the
Meeting.
For further information
Allergy Therapeutics +44 (0) 1903 845 820
Manuel Llobet, Chief Executive
Officer
Ian Postlethwaite, Finance
Director
Peel Hunt LLP +44 (0) 20 7418 8900
James Steel
Clare Terlouw
FTI Consulting +44 (0) 20 3727 1000
Simon Conway
Victoria Foster Mitchell
Notes to editors
About Allergy Therapeutics
Allergy Therapeutics is a specialty pharmaceutical company
focused on allergy vaccination. It has a growing business achieving
revenue in the last financial year of GBP42 million mainly in
Europe through its own sales and marketing infrastructure and
further afield through distributors. The Company is expanding its
infrastructure into the Emerging Markets.
This information is provided by RNS
The company news service from the London Stock Exchange
END
ACSBSBDGLBDBGSX
Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Feb 2024 to Mar 2024
Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Mar 2023 to Mar 2024